{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:08:55Z","timestamp":1778641735403,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"DOI":"10.1186\/s13052-026-02259-w","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T06:06:39Z","timestamp":1775109999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of two targeted rescue treatments after the first week of expectant managment for very preterm infants with hemodynamically significant patent ductus arteriosus: a prospective study"],"prefix":"10.1186","volume":"52","author":[{"given":"Leyao","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongshan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chongxun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongyi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianruo","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0374-2256","authenticated-orcid":false,"given":"Xiangyu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"issue":"5","key":"2259_CR1","doi-asserted-by":"publisher","first-page":"e20201209","DOI":"10.1542\/peds.2020-1209","volume":"146","author":"S Hamrick","year":"2020","unstructured":"Hamrick S, Sallmon H, Rose AT, et al. Patent ductus arteriosus of the preterm infant[J]. Pediatrics. 2020;146(5):e20201209. https:\/\/doi.org\/10.1542\/peds.2020-1209.","journal-title":"Pediatrics"},{"key":"2259_CR2","doi-asserted-by":"publisher","first-page":"729329","DOI":"10.3389\/fped.2021.729329","volume":"9","author":"J Shin","year":"2021","unstructured":"Shin J, Lee JA, Oh S, et al. Conservative treatment without any intervention compared with other therapeutic strategies for symptomatic patent ductus arteriosus in extremely preterm infants: a nationwide cohort study in Korea[J]. Front Pediatr. 2021;9:729329. https:\/\/doi.org\/10.3389\/fped.2021.729329.","journal-title":"Front Pediatr"},{"issue":"1","key":"2259_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/pch\/pxab085","volume":"27","author":"S Mitra","year":"2022","unstructured":"Mitra S, Weisz D, Jain A, et al. Management of the patent ductus arteriosus in preterm infants[J]. Paediatr Child Health. 2022;27(1):63\u20134. https:\/\/doi.org\/10.1093\/pch\/pxab085.","journal-title":"Paediatr Child Health"},{"issue":"3","key":"2259_CR4","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00431-020-03780-8","volume":"180","author":"C Dani","year":"2021","unstructured":"Dani C, Lista G, Bianchi S, et al. Intravenous paracetamol in comparison with ibuprofen for the treatment of patent ductus arteriosus in preterm infants: a randomized controlled trial[J]. Eur J Pediatr. 2021;180(3):807\u201316. https:\/\/doi.org\/10.1007\/s00431-020-03780-8.","journal-title":"Eur J Pediatr"},{"key":"2259_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4103\/ijpvm.IJPVM_387_19","volume":"12","author":"G Shahmirzadi","year":"2021","unstructured":"Shahmirzadi G, Nooripour S, Ziari A, et al. Comparison of gastrointestinal complications of paracetamol and ibuprofen in the management of infants with patent ductus arteriosus: a randomized clinical trial study[J]. Int J Prev Med. 2021;12:48. https:\/\/doi.org\/10.4103\/ijpvm.IJPVM_387_19.","journal-title":"Int J Prev Med"},{"issue":"8","key":"2259_CR6","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1001\/jamapediatrics.2020.1447","volume":"174","author":"SI Sung","year":"2020","unstructured":"Sung SI, Lee MH, Ahn SY, et al. Effect of nonintervention vs oral ibuprofen in patent ductus arteriosus in preterm infants: a randomized clinical trial[J]. JAMA Pediatr. 2020;174(8):755\u201363. https:\/\/doi.org\/10.1001\/jamapediatrics.2020.1447.","journal-title":"JAMA Pediatr"},{"key":"2259_CR7","doi-asserted-by":"publisher","first-page":"626261","DOI":"10.3389\/fped.2021.626261","volume":"9","author":"T Hundscheid","year":"2021","unstructured":"Hundscheid T, Jansen E, Onland W, et al. Conservative management of patent ductus arteriosus in preterm infants-a systematic review and meta-analyses assessing differences in outcome measures between randomized controlled trials and cohort studies[J]. Front Pediatr. 2021;9:626261. https:\/\/doi.org\/10.3389\/fped.2021.626261.","journal-title":"Front Pediatr"},{"issue":"11","key":"2259_CR8","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1056\/NEJMoa2207418","volume":"388","author":"T Hundscheid","year":"2023","unstructured":"Hundscheid T, Onland W, Kooi E, et al. Expectant management or early ibuprofen for patent ductus arteriosus[J]. N Engl J Med. 2023;388(11):980\u201390. https:\/\/doi.org\/10.1056\/NEJMoa2207418.","journal-title":"N Engl J Med"},{"key":"2259_CR9","doi-asserted-by":"publisher","first-page":"696417","DOI":"10.3389\/fphar.2021.696417","volume":"12","author":"ZY Xie","year":"2021","unstructured":"Xie ZY, Zhang RL, Xia YW, et al. Efficacy and safety of oral acetaminophen for premature infants with patent ductus arteriosus: a meta-analysis[J]. Front Pharmacol. 2021;12:696417. https:\/\/doi.org\/10.3389\/fphar.2021.696417.","journal-title":"Front Pharmacol"},{"key":"2259_CR10","doi-asserted-by":"publisher","unstructured":"Yang B, Gao X, Ren Y, et al. Oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants: a randomized controlled trial. Exp Ther Med 2016;12(4):2531\u20136. https:\/\/doi.org\/10.3892\/etm.2016.3676.","DOI":"10.3892\/etm.2016.3676"},{"issue":"12","key":"2259_CR11","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1001\/jama.2018.1896","volume":"319","author":"S Mitra","year":"2018","unstructured":"Mitra S, Florez ID, Tamayo ME, et al. Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants: a systematic review and meta-analysis[J]. JAMA. 2018;319(12):1221\u201338. https:\/\/doi.org\/10.1001\/jama.2018.1896.","journal-title":"JAMA"},{"issue":"5","key":"2259_CR12","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/s41372-021-01046-1","volume":"41","author":"K Hillier","year":"2021","unstructured":"Hillier K, Jones K, MacInnis M, et al. Comparison of standard versus high-dose ibuprofen for the treatment of hemodynamically significant patent ductus arteriosus in preterm infants[J]. J Perinatol. 2021;41(5):1142\u20138. https:\/\/doi.org\/10.1038\/s41372-021-01046-1.","journal-title":"J Perinatol"},{"key":"2259_CR13","first-page":"790","volume-title":"Avery\u2019s Diseases of the Newborn[M]","author":"CA Gleason","year":"2018","unstructured":"Gleason CA, Juul SE. Avery\u2019s Diseases of the Newborn[M]. 10th ed. Philadelphia: Elsevier; 2018. pp. 790\u2013800.","edition":"10"},{"key":"2259_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jpeds.2020.12.008","volume":"233","author":"JC Roz\u00e9","year":"2021","unstructured":"Roz\u00e9 JC, Cambonie G, Le Thuaut A, et al. Effect of early targeted treatment of ductus arteriosus with ibuprofen on survival without cerebral palsy at 2 years in infants with extreme prematurity: a randomized clinical trial[J]. J Pediatr. 2021;233:33\u2013e422. https:\/\/doi.org\/10.1016\/j.jpeds.2020.12.008.","journal-title":"J Pediatr"},{"issue":"12","key":"2259_CR15","doi-asserted-by":"publisher","first-page":"CD013278","DOI":"10.1002\/14651858.CD013278.pub2","volume":"12","author":"S Mitra","year":"2020","unstructured":"Mitra S, Scrivens A, von Kursell AM, et al. Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants[J]. Cochrane Database Syst Rev. 2020;12(12):CD013278. https:\/\/doi.org\/10.1002\/14651858.CD013278.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"2259_CR16","doi-asserted-by":"publisher","unstructured":"Huang D, Wang HY, Gao X. Research progress on rescue managements for preterm infants with patent ductus arteriosus after the first course of treatment failure. Chin J Neonatology 2020;35(6):465\u20138. https:\/\/doi.org\/10.3760\/cma.j.issn.2096-2932.2020.06.018.","DOI":"10.3760\/cma.j.issn.2096-2932.2020.06.018"},{"issue":"2","key":"2259_CR17","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1055\/s-0039-1697672","volume":"37","author":"RI Clyman","year":"2020","unstructured":"Clyman RI, Hills NK, Liebowitz M, et al. Relationship between duration of infant exposure to a moderate-to-large patent ductus arteriosus shunt and the risk of developing bronchopulmonary dysplasia or death before 36 weeks[J]. Am J Perinatol. 2020;37(2):216\u201323. https:\/\/doi.org\/10.1055\/s-0039-1697672.","journal-title":"Am J Perinatol"},{"key":"2259_CR18","doi-asserted-by":"publisher","unstructured":"Jasani B, Mitra S, Shah PS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database Syst Rev. 2022;12:CD010061. https:\/\/doi.org\/10.1002\/14651858.CD010061.pub5.","DOI":"10.1002\/14651858.CD010061.pub5"},{"key":"2259_CR19","doi-asserted-by":"publisher","unstructured":"Huang D, Ren Y, Gao X, et al. A case control study of patent ductus arteriosus in preterm infants treated with acetaminophen and platelet-rich plasma. Chin J Neonatol. 2019;34(2):109\u201314. https:\/\/doi.org\/10.3760\/cma.j.issn.2096-2932.2019.02.006.","DOI":"10.3760\/cma.j.issn.2096-2932.2019.02.006"},{"issue":"8","key":"2259_CR20","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s40620-022-01307-y","volume":"35","author":"J Kuo","year":"2022","unstructured":"Kuo J, Akison LK, Chatfield MD, et al. Serum and urinary biomarkers to predict acute kidney injury in premature infants: a systematic review and meta-analysis of diagnostic accuracy[J]. J Nephrol. 2022;35(8):2001\u201314. https:\/\/doi.org\/10.1007\/s40620-022-01307-y.","journal-title":"J Nephrol"},{"issue":"4","key":"2259_CR21","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/s41390-020-0965-8","volume":"89","author":"A Barbati","year":"2021","unstructured":"Barbati A, Aisa MC, Cappuccini B, et al. Urinary Cystatin-C, a marker to assess and monitor neonatal kidney maturation and function: validation in twins[J]. Pediatr Res. 2021;89(4):932\u20139. https:\/\/doi.org\/10.1038\/s41390-020-0965-8.","journal-title":"Pediatr Res"},{"issue":"25","key":"2259_CR22","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.2174\/1381612824666180918100819","volume":"24","author":"N Khosravi","year":"2018","unstructured":"Khosravi N, Zadkarami M, Chobdar F, et al. The Value of Urinary Cystatin C Level to Predict Neonatal Kidney Injury. Curr Pharm Des[J]. 2018;24(25):3002\u20134. https:\/\/doi.org\/10.2174\/1381612824666180918100819.","journal-title":"Curr Pharm Des[J]"},{"key":"2259_CR23","doi-asserted-by":"publisher","unstructured":"Ting JY, McDougal K, De Mello A, et al. Acute kidney injury among preterm infants receiving nonsteroidal anti-inflammatory drugs: a pilot study. Pediatr Neonatol. 2022;S1875-9572(22)00255-8. https:\/\/doi.org\/10.1016\/j.pedneo.2022.06.018.","DOI":"10.1016\/j.pedneo.2022.06.018"},{"issue":"12","key":"2259_CR24","doi-asserted-by":"publisher","first-page":"CD013129","DOI":"10.1002\/14651858.CD013129.pub2","volume":"12","author":"G Gokulakrishnan","year":"2022","unstructured":"Gokulakrishnan G, Kulkarni M, He S, et al. Brain natriuretic peptide and N-terminal brain natriuretic peptide for the diagnosis of haemodynamically significant patent ductus arteriosus in preterm neonates[J]. Cochrane Database Syst Rev. 2022;12(12):CD013129. https:\/\/doi.org\/10.1002\/14651858.CD013129.pub2.","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-026-02259-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-026-02259-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-026-02259-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:17:39Z","timestamp":1778638659000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13052-026-02259-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2259"],"URL":"https:\/\/doi.org\/10.1186\/s13052-026-02259-w","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"22 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study meets the requirements of medical ethics, has been approved by the Medical Ethics Committee of our hospital, and has been registered with the Chinese Clinical Trial Registry(ChiCRT2200056444).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Parents of the affected infants are aware of the treatment methods and have signed informed consent forms.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}